pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Preclinical
    BP-1003
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$BPTH BIO-PATH HOLDINGS, INC.
  • Preclinical
    BP-2202
    Multiple Myeloma (Kahler Disease) BrightPath Biotherapeutics Co Ltd
  • Preclinical
    BPA
    Glioblastoma Multiforme (GBM) TAE Life Sciences LLC
  • Preclinical
← prev
page 13 of 62
next →
Pain89
Neurology1
BRST-33
Breast Cancer
$CNBX CNBX Pharmaceuticals Inc.
  • Phase 2
    BS-001
    Melanoma Wuhan Binhui Biopharmaceutical Co Ltd
  • Phase 2
    BSI-04702
    Solid Tumor OBI Pharma Inc
  • Phase 1
    BSI-082
    Solid Tumor Biosion Inc
  • Preclinical
    BT-1501
    Colorectal Cancer Barricade Therapeutics Corp
  • Phase 2
    BT-7480
    Anal Cancer$BCYC BICYCLE THERAPEUTICS PLC
  • Phase 2
    BTM-3566
    Burkitt Lymphoma Bantam Pharmaceutical LLC
  • Phase 1
    BTX-9341
    Human Epidermal Growth Factor Receptor 2 Negative Breast… BioTheryX Inc
  • Phase 2
    BTXA-51
    Refractory Acute Myeloid Leukemia Edgewood Oncology Inc
  • Preclinical
    BVA-501
    Glioblastoma Multiforme (GBM) Biovista Inc
  • Preclinical
    BVA-701
    Glioblastoma Multiforme (GBM) Biovista Inc
  • Preclinical
    BVX-001
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Bivictrix Therapeutics Ltd
  • Phase 2
    BXQ-350
    Metastatic Colorectal Cancer Bexion Pharmaceuticals Inc
  • Preclinical
    BY-103
    Blood Cancer BoYen Therapeutics Inc
  • Phase 1
    Bapotulimab
    Head And Neck Squamous Cell Carcinoma (HNSC) Bayer AG
  • Phase 1
    Biostage Esophageal Implant
    Esophageal Cancer$HRGN Harvard Apparatus Regenerative Technology, Inc.
  • Phase 1
    Breast Cancer Vaccine
    Triple-Negative Breast Cancer (TNBC)$ANIX Anixa Biosciences Inc
  • Phase 3
    Bria-IMT
    BriaVax
    Human Epidermal Growth Factor Receptor 2 Low Breast Cance…$BCTX BriaCell Therapeutics Corp.
  • Phase 2
    Bria-OTS
    Bria-OTS
    Lung Cancer$BCTX BriaCell Therapeutics Corp.
  • Preclinical
    Bria-Pros
    Metastatic Prostate Cancer$BCTX BriaCell Therapeutics Corp.
  • Preclinical
    CA-IL-12
    Triple-Negative Breast Cancer (TNBC) Cytonus Therapeutics Inc
  • Phase 1
    CAL-056
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Calgent Biotechnology Co Ltd
  • Phase 1
    CAP-100
    Refractory Chronic Lymphocytic Leukemia (CLL) Catapult Therapeutics BV
  • Phase 1
    CB-011
    Refractory Multiple Myeloma$CRBU Caribou Biosciences, Inc.
  • Phase 1
    CB-11
    Glioblastoma Multiforme (GBM) Cellebrain Co Ltd
  • Preclinical
    CB-303
    Solid Tumor CentricsBio Inc
  • Phase 1
    CBI-1214
    Metastatic Colorectal Cancer Cartography Biosciences Inc